Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.1017/S0022215120001826

http://scihub22266oqcxt.onion/10.1017/S0022215120001826
suck pdf from google scholar
32782030!7471571!32782030
unlimited free pdf from europmc32782030    free
PDF from PMC    free
html from PMC    free

suck abstract from ncbi

pmid32782030      J+Laryngol+Otol 2020 ; 134 (8): 703-709
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • Smell and taste recovery in coronavirus disease 2019 patients: a 60-day objective and prospective study #MMPMID32782030
  • Vaira LA; Hopkins C; Petrocelli M; Lechien JR; Chiesa-Estomba CM; Salzano G; Cucurullo M; Salzano FA; Saussez S; Boscolo-Rizzo P; Biglioli F; De Riu G
  • J Laryngol Otol 2020[Aug]; 134 (8): 703-709 PMID32782030show ga
  • BACKGROUND: The long-term recovery rate of chemosensitive functions in coronavirus disease 2019 patients has not yet been determined. METHOD: A multicentre prospective study on 138 coronavirus disease 2019 patients was conducted. Olfactory and gustatory functions were prospectively evaluated for 60 days. RESULTS: Within the first 4 days of coronavirus disease 2019, 84.8 per cent of patients had chemosensitive dysfunction that gradually improved over the observation period. The most significant increase in chemosensitive scores occurred in the first 10 days for taste and between 10 and 20 days for smell. At the end of the observation period (60 days after symptom onset), 7.2 per cent of the patients still had severe dysfunctions. The risk of developing a long-lasting disorder becomes significant at 10 days for taste (odds ratio = 40.2, 95 per cent confidence interval = 2.204-733.2, p = 0.013) and 20 days for smell (odds ratio = 58.5, 95 per cent confidence interval = 3.278-1043.5, p = 0.005). CONCLUSION: Chemosensitive disturbances persisted in 7.2 per cent of patients 60 days after clinical onset. Specific therapies should be initiated in patients with severe olfactory and gustatory disturbances 20 days after disease onset.
  • |Adult[MESH]
  • |Betacoronavirus/isolation & purification[MESH]
  • |COVID-19[MESH]
  • |Coronavirus Infections/*complications/epidemiology/therapy/virology[MESH]
  • |Female[MESH]
  • |Humans[MESH]
  • |Italy/epidemiology[MESH]
  • |Male[MESH]
  • |Middle Aged[MESH]
  • |Olfaction Disorders/diagnosis/etiology/virology[MESH]
  • |Pandemics[MESH]
  • |Pneumonia, Viral/*complications/epidemiology/therapy/virology[MESH]
  • |Prospective Studies[MESH]
  • |Recovery of Function[MESH]
  • |SARS-CoV-2[MESH]
  • |Smell/drug effects/*physiology[MESH]
  • |Taste Disorders/diagnosis/etiology/virology[MESH]


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    Linkout box